AKT1 and metabolic dysfunction-associated steatotic liver disease: Oleic acid (36:2) has been reported to be elevated with hepatic lipogenesis and also shown to activate androgen receptor–mediated AKT stimulation, a putative pathway linked to higher risk of HCC development in obese patients with NAFLD, with a male sex predominance (44).